AT332539B - Verfahren zur herstellung eines immunisierungsmittels - Google Patents

Verfahren zur herstellung eines immunisierungsmittels

Info

Publication number
AT332539B
AT332539B AT975872A AT975872A AT332539B AT 332539 B AT332539 B AT 332539B AT 975872 A AT975872 A AT 975872A AT 975872 A AT975872 A AT 975872A AT 332539 B AT332539 B AT 332539B
Authority
AT
Austria
Prior art keywords
manufacturing
immunizing agent
immunizing
agent
Prior art date
Application number
AT975872A
Other languages
English (en)
Other versions
ATA975872A (de
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Priority to AT775675A priority Critical patent/AT332551B/de
Publication of ATA975872A publication Critical patent/ATA975872A/de
Application granted granted Critical
Publication of AT332539B publication Critical patent/AT332539B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT975872A 1971-11-17 1972-11-16 Verfahren zur herstellung eines immunisierungsmittels AT332539B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT775675A AT332551B (de) 1971-11-17 1975-10-10 Verfahren zur herstellung eines antilipoid-a-serums

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (2)

Publication Number Publication Date
ATA975872A ATA975872A (de) 1976-01-15
AT332539B true AT332539B (de) 1976-10-11

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT975872A AT332539B (de) 1971-11-17 1972-11-16 Verfahren zur herstellung eines immunisierungsmittels

Country Status (10)

Country Link
JP (1) JPS5512002B2 (de)
AT (1) AT332539B (de)
BE (1) BE791489A (de)
CH (1) CH588867A5 (de)
DD (1) DD102410A5 (de)
DE (1) DE2157148A1 (de)
FR (1) FR2160542B1 (de)
GB (1) GB1416544A (de)
NL (1) NL7215221A (de)
SE (1) SE406419B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
EP2934580B1 (de) * 2012-12-20 2019-09-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Polyvalentes kombiniertes immunisierendes und/oder therapeutisches präparat zur verwendung bei bakteriellen infektionen oder lebensmittelvergiftung, insbesondere salmonellose, verfahren zur herstellung dieses präparats, dessen verwendung und impfstoff mit diesem präparat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
BE791489A (fr) 1973-05-16
CH588867A5 (de) 1977-06-15
DD102410A5 (de) 1973-12-12
FR2160542A1 (de) 1973-06-29
AU4902772A (en) 1974-05-23
JPS4861621A (de) 1973-08-29
JPS5512002B2 (de) 1980-03-29
SE406419B (sv) 1979-02-12
GB1416544A (en) 1975-12-03
DE2157148A1 (de) 1973-05-24
FR2160542B1 (de) 1976-04-23
ATA975872A (de) 1976-01-15
NL7215221A (de) 1973-05-21

Similar Documents

Publication Publication Date Title
AT324578B (de) Verfahren zur herstellung eines wundverbandes
AT322400B (de) Verfahren zur herstellung eines schleifkoerpers
AT321082B (de) Verfahren zur Herstellung eines Nahrungsmittels
AT336882B (de) Verfahren zur herstellung von rohren
AT333146B (de) Verfahren zur herstellung eines schleifmittels
AT316756B (de) Verfahren zur herstellung eines lactulosepulvers
AT342789B (de) Verfahren zur herstellung eines injizierbaren komplexes
CH553435A (de) Verfahren zur herstellung eines koronageneratordrahtes.
AT326354B (de) Verfahren zur herstellung eines pfropf-copolymeren
AT332531B (de) Verfahren zur herstellung eines nierensteinlosenden praparates
AT334725B (de) Verfahren zur herstellung eines eiersatzes
AT340680B (de) Verfahren zur herstellung eines pfropfcopolymers
AT332539B (de) Verfahren zur herstellung eines immunisierungsmittels
AT317435B (de) Verfahren zur Herstellung eines antiseborrhoisch wirksamen Mittels
AT331024B (de) Verfahren zur herstellung eines elastomerlatex
AT314736B (de) Verfahren zur herstellung eines lactulosepulvers
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT321869B (de) Verfahren zur herstellung eines eisenhaltigen wismut-phosphor molybdat-trägerkatalysators
CH499897A (de) Verfahren zur Herstellung eines Supraleiters
AT327412B (de) Verfahren zur herstellung von prostaglandinen
AT317147B (de) Verfahren zur Herstellung eines Schlichtemittels
AT347817B (de) Verfahren zur herstellung eines schuhes
AT333027B (de) Verfahren zur herstellung eines harzes
DE2145866B2 (de) Verfahren zur herstellung eines nachrichtenkabels
DE2113553B2 (de) Verfahren zur herstellung eines leiterbildes

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee